9
Total investments
0
Early stage
2
Mid stage
1
Late stage
20y
Years active
Portfolio
4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
Dec 2024
Novel Bio makes radically better plasmid DNA for genetic medicines. Accelerate your pipeline with reliable, high-quality plasmids for even your toughest designs, delivered by real DNA experts. We aim to overcome the DNA bottleneck and help bring a new generation of medicine to patients.
Board Member
Sep 2021
Intterra is the geospatial intelligence platform that delivers real-time data and insights to enhance public safety and emergency management. Trusted by law enforcement, fire, emergency teams, and governments, Intterra empowers decision-makers to act swiftly and confidently when it matters most.
Board Observer
Jun 2020
Absci is a data-first AI drug creation company designing differentiated therapeutics using generative AI. Our Integrated Drug Creation platform powers cutting-edge de novo AI models and AI lead optimization models aimed at designing better biologics against difficult-to-drug targets.
Advisor & Investor
Jan 2018
The Dyrt is the largest consumer subscription software platform for campers in the US. The Dyrt community has crowdsourced over 8 million campground reviews, photos and tips across the US - more than any other camping platform. The Dyrt app is a top ranked app for camping in both iOS and Google Play, and their website is tracking at 30M visits per year.
The Dyrt is an open community that lets campers search, review and book campgrounds. The Dyrt PRO (a $36 per year upgrade subscription) gives PRO users discounts at nearly 1000 campgrounds, as well as provides enhanced camping search features such as public land map layers, offline access, and road trip planning tools. The Dyrt PRO subscription was launched in 2020 and has experienced rapid growth with a new user signing up for The Dyrt PRO about every 3 minutes.
Experience · 14 entries
All (14)
Investments (9)
Founder (4)
Board (8)
2024
Board Observer
Dec 2024
Novel Bio makes radically better plasmid DNA for genetic medicines. Accelerate your pipeline with reliable, high-quality plasmids for even your toughest designs, delivered by real DNA experts. We aim to overcome the DNA bottleneck and help bring a new generation of medicine to patients.
2021
Board Member
Sep 2021
Intterra is the geospatial intelligence platform that delivers real-time data and insights to enhance public safety and emergency management. Trusted by law enforcement, fire, emergency teams, and governments, Intterra empowers decision-makers to act swiftly and confidently when it matters most.
2020
Board Observer
Jun 2020
Absci is a data-first AI drug creation company designing differentiated therapeutics using generative AI. Our Integrated Drug Creation platform powers cutting-edge de novo AI models and AI lead optimization models aimed at designing better biologics against difficult-to-drug targets.
2019
C
Cross Pollinate
Founder
Jul 2019
Founder & President
Jul 2019
The organization brings together wealth creators, family champions and support staff to share ideas, solve problems, and learn from one another in a curated, confidential, peer-to-peer environment.
Show all 14 entries ↓
Investment activity
2006–2024 · 9 investments
Recent (last 2 years)Earlier
